BIOMAT Database Logo BIOMAT Database Logo

Antithymocyte globulin for steroid resistant rejection in renal transplant recipients immunosuppressed with triple therapy. 1989

A J Richardson, and R M Higgins, and M Liddington, and J Murie, and A Ting, and P J Morris
Nuffield Department of Surgery Transplant Unit, University of Oxford, Churchill Hospital, Headington, UK.

Steroid resistant rejection, confirmed histologically, occurred in 35 of 187 consecutive cadaveric renal transplants treated with triple therapy (cyclosporin, azathioprine and prednisolone) in the Oxford Transplant Unit. Twenty-seven of these were treated with a rabbit antithymocyte globulin (ATG) and 19 showed recovery of function. The level of serum creatinine, the renal biopsy appearance and the requirement for dialysis at the start of ATG treatment did not predict which patients would respond to the therapy. One year after transplantation there was no significant difference between the mean plasma creatinine levels of those patients with steroid resistant rejection who had been given ATG and responded (151.6 mumol/l) and those who had responded to steroids alone (165.0 mumol/l). Adverse effects of ATG treatment included a mean fall in white cell count of 62.2% and a mean fall in platelet count of 45.1%. Two of the 27 patients who received ATG died (7.4% mortality). ATG would appear to be an effective treatment of steroid resistant rejection in patients receiving triple therapy immunosuppression, and graft function may subsequently be excellent in those patients who respond to treatment.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D001772 Blood Cell Count The number of LEUKOCYTES and ERYTHROCYTES per unit volume in a sample of venous BLOOD. A complete blood count (CBC) also includes measurement of the HEMOGLOBIN; HEMATOCRIT; and ERYTHROCYTE INDICES. Blood Cell Number,Blood Count, Complete,Blood Cell Counts,Blood Cell Numbers,Blood Counts, Complete,Complete Blood Count,Complete Blood Counts,Count, Blood Cell,Count, Complete Blood,Counts, Blood Cell,Counts, Complete Blood,Number, Blood Cell,Numbers, Blood Cell
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females

Related Publications

A J Richardson, and R M Higgins, and M Liddington, and J Murie, and A Ting, and P J Morris
Antilymphoblast globulin treatment of steroid-resistant rejection in cyclosporine-immunosuppressed renal transplant recipients.
February 1987, Transplantation proceedings,
A J Richardson, and R M Higgins, and M Liddington, and J Murie, and A Ting, and P J Morris
Use of antithymocyte globulin and cyclosporine to treat steroid-resistant rejection episodes in renal transplant recipients.
February 1987, Transplantation proceedings,
A J Richardson, and R M Higgins, and M Liddington, and J Murie, and A Ting, and P J Morris
Rabbit anti-thymocyte globulin treatment of steroid resistant rejection in renal allograft recipients immunosuppressed with cyclosporine A.
February 1989, Transplantation proceedings,
A J Richardson, and R M Higgins, and M Liddington, and J Murie, and A Ting, and P J Morris
Pretransplant thymic function predicts acute rejection in antithymocyte globulin-treated renal transplant recipients.
May 2016, Kidney international,
A J Richardson, and R M Higgins, and M Liddington, and J Murie, and A Ting, and P J Morris
A comparison of outcomes between OKT3 and antithymocyte globulin for treatment of steroid-resistant rejection in hepatitis C liver transplant recipients.
February 2014, Transplantation,
A J Richardson, and R M Higgins, and M Liddington, and J Murie, and A Ting, and P J Morris
Value of cyclosporine measurements in renal transplant recipients immunosuppressed with triple therapy.
June 1990, Transplantation proceedings,
A J Richardson, and R M Higgins, and M Liddington, and J Murie, and A Ting, and P J Morris
Rabbit Antithymocyte Globulin Induction in Heart Transplant Recipients at High Risk for Rejection.
January 2021, Ochsner journal,
A J Richardson, and R M Higgins, and M Liddington, and J Murie, and A Ting, and P J Morris
Induction treatment with rabbit antithymocyte globulin versus basiliximab in renal transplant recipients with planned early steroid withdrawal.
June 2011, Pharmacotherapy,
A J Richardson, and R M Higgins, and M Liddington, and J Murie, and A Ting, and P J Morris
Methotrexate for lung transplant recipients with steroid-resistant acute rejection.
November 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
A J Richardson, and R M Higgins, and M Liddington, and J Murie, and A Ting, and P J Morris
Short-course antithymocyte globulin for treatment of renal transplant rejection in children.
January 1986, Transplantation,
Copied contents to your clipboard!